Last reviewed · How we verify
Spinal analgesia with bupivacaine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Spinal analgesia with bupivacaine (Spinal analgesia with bupivacaine) — Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Spinal analgesia with bupivacaine TARGET | Spinal analgesia with bupivacaine | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Spinal analgesia with bupivacaine CI watch — RSS
- Spinal analgesia with bupivacaine CI watch — Atom
- Spinal analgesia with bupivacaine CI watch — JSON
- Spinal analgesia with bupivacaine alone — RSS
Cite this brief
Drug Landscape (2026). Spinal analgesia with bupivacaine — Competitive Intelligence Brief. https://druglandscape.com/ci/spinal-analgesia-with-bupivacaine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab